Rich Pharmaceuticals competitors

Rich Pharmaceuticals Competitors include GTx, Rexahn Pharmaceuticals, Burzynski Research Institute and Alpine Immune Sciences.
Add company...
Rich Pharmaceuticals
Rich Pharmaceuticals
Rich Pharmaceuticals is a biopharmaceutical company that is focused on the development of its lead product, RP-323, for the treatment of acute myelogenous leukemia in refractory patients.
GTx
GTx
GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
Burzynski Research Institute
Burzynski Research Institute
Burzynski Research Institute is primarily engaged as a research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer.
Alpine Immune Sciences
Alpine Immune Sciences
Modern therapies targeting the immune synapse.
Founding Date
Founding Date
N/A
Founding Date
1997
Founding Date
2001
Founding Date
1984
Founding Date
2015
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Beverly Hills, US HQ
Locations
Memphis, US HQ
Locations
Rockville, US HQ
Locations
Houston, US HQ
Stafford, US
Locations
Seattle, US HQ
Employees
Employees
1
Employees
274% increase
Employees
1715% decrease
Employees
2
Employees
N/A
Valuation ($)
Valuation ($)
206.6 k
Valuation ($)
23.1 m
Valuation ($)
47.3 m
Valuation ($)
4 m
Valuation ($)
N/A

Financial

Net income
Net income
N/A
Net income
($30.4m) (FY, 2017)
Net income
($25.3m) (FY, 2017)
Net income
($1.6m) (FY, 2018)
Net income
($7.8m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 64.7m
Total funding raised
$ 5m
Total funding raised
N/A
Total funding raised
$ 49.3m
For sources of this data, please see the company profileDownload Excel

View company profiles

GTx
HQ
Memphis, US
Employees
27↑ 4% increase

GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.

View company
Rexahn Pharmaceuticals
HQ
Rockville, US
Employees
17↓ 15% decrease

Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.

View company
Burzynski Research Institute
HQ
Houston, US
Employees
2

Burzynski Research Institute is primarily engaged as a research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer.

View company
Alpine Immune Sciences
HQ
Seattle, US

Modern therapies targeting the immune synapse.

View company